USE OF BREASTFEEDING EXOSOMES AS RADIOISOTOPE VEHICLES FOR THE DIAGNOSIS AND TREATMENT OF NEOPLASMS
DE602021052625T2Active Publication Date: 2026-04-22FUNDACION AGENCIA ARAGONESA PARA LA INVESTIGACION Y EL DESARROLLO ARAID +3
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- FUNDACION AGENCIA ARAGONESA PARA LA INVESTIGACION Y EL DESARROLLO ARAID
- Filing Date
- 2021-03-29
- Publication Date
- 2026-04-22
AI Technical Summary
Technical Problem
The challenge lies in developing efficient and safe transport vehicles that can specifically target and deliver therapeutic agents, including radioisotopes, to tumor sites, including central hypoxic regions, to improve theragnosis in tumors.
Method used
Utilizing exosomes derived from breast milk that express high levels of the sodium-iodine symporter (NIS) to accumulate radioisotopes, enabling targeted visualization and treatment of tumors and metastases through techniques like PET or SPECT, and therapeutic agents like 131I.
Benefits of technology
Exosomes effectively accumulate radioisotopes in tumors, allowing for precise diagnosis and treatment with minimal side effects, as they exhibit high tumor selectivity and tropism, avoiding ethical concerns and invasive methods.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.